Changes

Jump to navigation Jump to search
33 bytes added ,  15:52, 6 November 2010
Line 18: Line 18:  
==Route of Administration==
 
==Route of Administration==
 
*Usually by subcutaneous injection for '''systemic''' protection ([[Immunoglobulin G|IgG]]). Some vaccines such as the [[Myxomatosis|myxomatosis]] vaccine NobivacTM Myxo (Intervet UK Ltd) require an intradermal injection as part of the administration procedure.
 
*Usually by subcutaneous injection for '''systemic''' protection ([[Immunoglobulin G|IgG]]). Some vaccines such as the [[Myxomatosis|myxomatosis]] vaccine NobivacTM Myxo (Intervet UK Ltd) require an intradermal injection as part of the administration procedure.
*For a localised '''mucosal''' immune response, intranasal administration is best ([[Immunoglobulin A|IgA]])
+
*For a localised '''mucosal''' immune response, intranasal administration is required ([[Immunoglobulin A|IgA]]) - e.g. kennel cough vaccine.
    
==What do we vaccinate with?==
 
==What do we vaccinate with?==
5,582

edits

Navigation menu